SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Feb 15, 2018

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Feb. 15, 2018 · CIK: 0001585608 · Accession: 0000000000-18-005268

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36714

Date

February 15, 2018

Author

Lisa A. Conte

Form

UPLOAD

Company

Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

February 15, 2018 Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, California 94105 Re:Jaguar Health, Inc. Preliminary Proxy Statement on Schedule 14A Filed February 6, 2018 File No. 001-36714 Dear Ms. Conte: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence by the staff. Division of Corporation Finance Office of Healthcare & Insurance cc: Donald C. Reinke, Esq.

Show Raw Text

February 15, 2018
Lisa A. Conte
Chief Executive Officer and President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, California 94105
Re:Jaguar Health, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed February 6, 2018
File No. 001-36714
Dear Ms. Conte:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Donald C. Reinke, Esq.

SecProbe.io